Andrew Norden

A Trusted Treatment Option from Watson: Why Concordance Studies Matter

Hearing diverse opinions from multiple oncologists is an important part of a patient’s journey, what’s often referred to as getting a second – or third – opinion. And cancer docs, too, frequently consult with one another to confirm a decision or provide a new idea. That’s understandable because cancer is a complex and sometimes elusive […]

Continue reading

Putting Watson to the Test for Cancer Care

As a practicing neuro-oncologist, I believe in a collaborative approach to cancer care – involving the patient, their family, caregivers and a variety of clinical specialists. The cancer journey is challenging in so many ways that “going it alone” just isn’t an option if your goal is the best possible outcome. And today, with the […]

Continue reading